LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
NAUTCIK 0001808805

Nautilus Biotechnology, Inc.

15 transactions by 13 insiders, from March 2, 2026 to June 18, 2026.

Transactions
1513 insiders
Bought · P
$65Kopen market
Sold · S
$11.8Mopen market
Net
−$11.7Mnet selling

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Sujal M. PatelCEO2—$65K—
Matthew S. McIlwainDir1———
Matthew L. PosardDir1———
Karen AkinsanyaDir1———
Melissa B. EpperlyDir1———
Subramanian SankarVP1———
Anna MowryCFO1———
Parag MallickChief1———
Matthew B. MurphyGC1———
Farzad NazemDir1———
Kentaro SuzukiChief1———
Gwen E. WeldChief1———

Large holders and funds

Holders above 10%, often funds. They file the same form, but they trade for portfolio reasons, not because of what they know.

InsiderTradesPlannedBoughtSold
AH Equity Partners Bio II, L.L.C.10%2——$11.8M

All transactions

15 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Matthew L. PosardDirDERIVJun 18A45,000$0.00—?
Farzad NazemDirDERIVJun 18A45,000$0.00—?
Matthew S. McIlwainDirDERIVJun 18A45,000$0.00—?
Melissa B. EpperlyDirDERIVJun 18A45,000$0.00—?
Karen AkinsanyaDirDERIVJun 18A45,000$0.00—?
AH Equity Partners Bio II, L.L.C.10%JOINTJun 2S384,026$2.35$902K
AH Equity Partners Bio II, L.L.C.10%JOINTJun 2S4,615,974$2.35$10.8M
Kentaro SuzukiChiefDERIVMar 2A160,000$0.00—?
Subramanian SankarVPDERIVMar 2A160,000$0.00—?
Gwen E. WeldChiefDERIVMar 2A160,000$0.00—?
Sujal M. PatelCEOMar 4P25,000$2.61$65K
Sujal M. PatelCEODERIVMar 2A650,000$0.00—?
Matthew B. MurphyGCDERIVMar 2A160,000$0.00—?
Anna MowryCFODERIVMar 2A160,000$0.00—?
Parag MallickChiefDERIVMar 2A280,000$0.00—?